Prof. Charles L. Cooney
Intensification, Integration and Interrogation of Bioprocesses
June 2nd, Cambridge, MA
Rapid progress in biotechnology is poised to change the world in the years to come. However, the ever-increasing complexity of medicine confronts bioprocessing with significant challenges. Novel manufacturing technologies such as Single-Use or Continuous Manufacturing are still in an early stage of implementation.
We at Levitronix® believe that to build on the progress that the industry has made, end users, system- and component suppliers must come together to reinforce what it takes to foster the trust and tight collaboration that’s vital to the future success of bioprocessing.
The Levitronix® Bioprocessing Conference brings industry professionals together to make change.
Book your free pass and become part of a community that believes in progress through collaboration.
The ideal location for experiencing all the things to do in Cambridge and Boston – everything you need is easily accessible to get the most out of your trip.
Hotel Royal Sonesta Boston
40 Edwin Land Boulevard
Cambridge
MA 02142
USA
Please fill out the form on the right to book your free pass for the Levitronix® Bioprocessing Conference taking place on June, 2nd 2022 in Boston, MA.
Any questions regarding the event?
Don’t hesitate to contact us: lbc@levitronix.com
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
press "esc" to close
Charles L. Cooney is the Robert T. Haslam (1911) Professor of Chemical and Biochemical Engineering, Emeritus in the Department of Chemical Engineering at MIT and founding Faculty Director, Emeritus of the Deshpande Center for Technological Innovation. His academic career has focused on biotech and pharma process design, operation, economics and control; continuous processing has been a reoccurring theme throughout his research. He has been involved as founder, advisor or board member of over 25 companies and currently sits on the Boards of Directors of Codiak Bioscience, Innovent Biologics (1801.HK), Elektrofi, Iterative Scopes, Levitronix Technologies, LayerBio, Boyd Technologies and is chairman of GreenLight Bioscience. He was a member of the FDA Pharmaceutical Sciences Advisory Committee 2003-2006 and chair from 2005-2006. Prof. Cooney’s research and teaching interests span a range of topics in biochemical engineering, pharmaceutical manufacturing and technological innovation. He has published over 250 research papers, over 25 patents and co-authored or edited 5 books including Development of Sustainable Bioprocesses: Modeling and Assessment, Wiley Press 2006. His teaching has focused on bioprocess development and manufacturing and technological innovation and is interested in the process of stimulating technological innovation and its translation from the university into new company creation.
With increasing emphasis on biotherapeutics to meet unmet medical needs, continued scaling of global production and the introduction of new therapeutic modalities, we see a continuing need to develop bioprocesses faster and less expensively with assurance of high quality. The strategy to achieve these goals involves three pillars: process intensification to reduce both variable and fixed costs, through high productivity, process integration to enhance speed of manufacturing and assure robust outcomes, and process interrogation to implement process control with on-line monitoring to assure consistent high product quality and minimal cost. These pillars provide a framework that provides guidance to those developing the tools and the processes supporting biotherapeutics manufacturing.
press "esc" to close
Coming soon
Coming soon
press "esc" to close
Coming soon
Coming soon
press "esc" to close
Coming soon
Coming soon